SCHEMBL10242216

SCHEMBL10242216

C[C@@H]1NC(=O)O[C@@H]1C1CCCC1

nearest known ligand 0.30

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 2/20 0.30
▸ CA2 P00918 1/20 0.30
▸ CA4 P22748 1/20 0.30
▸ CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10242120 0.98 MAPT (0.32) —
SCHEMBL11684385 0.74 ALDH1A1 (0.33) —
SCHEMBL10110368 0.66 — —
SCHEMBL22313102 0.66 — —
SCHEMBL4026362 0.66 — —
SCHEMBL14231549 0.66 — —
SCHEMBL16438955 0.65 KMT2A (0.34) CA1CA2CA4CA9
SCHEMBL22559981 0.65 LMNA (0.37) CA1CA2CA4
SCHEMBL20794170 0.63 CHRM2 (0.30) —
SCHEMBL15743938 0.63 CHRM2 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1765793-B1 ANACETRAPIB AND OTHER CETP INHIBITPRS MERCK SHARP & DOHME (US) 2012-09-26 — — EP disclosed
EP-2415759-A1 CETP inhibitors Merck Sharp & Dohme Corporation (US) 2012-02-08 — — EP disclosed
Send feedback